Author(s):
Ragul Viknesh V, Saranya P
Email(s):
saro08bpharm@gmail.com
DOI:
10.5958/0974-360X.2020.00697.6 
Address:
Ragul Viknesh V1, Saranya P2*
1Pharmd Intern, Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai-600117, Tamil Nadu, India.
2Associate Professor, Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai-600117, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 8,
Year - 2020
ABSTRACT:
The Pharmacovigilance is the scientific activity of identification, evaluation, understanding, and prevention of adverse drugs reactions and other medication-related issues. An “adverse drug reaction” is any hazard, unwanted effect of a drug, which occurs in a normal dose used in humans for prophylaxis, diagnosis, therapy or modification of physiological functions. In India Pharmacovigilance was started in 1986 but it is failed due to various reasons. The Present Pharmacovigilance Program initiated in 2010 and progressing successfully. The aim of the Pharmacovigilance program of India is establishing Indian ADR reporting system and to create own ADR database for the country. The under-reporting of ADR is an important challenge for PVPI to overcome these Technological advancements should be involved. The pharmacist is an integral part of PVPI because of their role in the various levels of the Health care system and immense knowledge about drugs. Hospital pharmacist plays a significant role since most serious ADR occurs in Hospitals. The tremendous growth of Pharmaceutical Industries and Clinical research leads to expansion of PVPI in India. In future PVPI planned to introduce a course on Pharmacovigilance to medical and paramedical students to promote drug safety. The Pharmacovigilance program helps to promote ADR reporting and educate Health care professionals to assure patient confidence in Health care system.
Cite this article:
Ragul Viknesh V, Saranya P. Pharmacovigilance - An Overview in a Pharmacist Perspective. Research J. Pharm. and Tech. 2020; 13(8):3941-3946. doi: 10.5958/0974-360X.2020.00697.6
Cite(Electronic):
Ragul Viknesh V, Saranya P. Pharmacovigilance - An Overview in a Pharmacist Perspective. Research J. Pharm. and Tech. 2020; 13(8):3941-3946. doi: 10.5958/0974-360X.2020.00697.6 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-8-70
REFERENCES:
1. WHO Definition of Pharmacovigilance. 2002.
2. WHO Pharmacovigilance Guidelines, (https:// www.who.int/Medicines/areas/quality_safety/safety_efficacy/S.AfricaDraftGuidelines.pdf)
3. WHO. The safety of medicines in public health programmes. Pharmacovigilance an essential tool. WHO Drug Information Vol. 32, No. 1, 2018.
4. Dogra, R and Garg, R and Kumar, V and Verma, V and Tripathi, V. (2013). Detection, assessment, understanding and prevention of adverse effects: Pharmacovigilance: A review. International Journal of Pharmaceutical Sciences Review and Research. 20. 71-86.
5. Wal P, Wal A, Gupta S, Sharma G, Rai A. Pharmacovigilance of herbal products in India. J Young Pharm. 2011;3(3):256-8.
6. Jeetu, G., and Anusha, G. (2010). Pharmacovigilance: a worldwide master key for drug safety monitoring. Journal of young pharmacists : JYP, 2(3), 315–320. doi:10.4103/0975-1483.66802
7. Saleh, Samira. (2012). Why do we need Pharmacovigilance?. 10.13140/2.1.4162.6882.
8. Sowmyanarayan S. Need For Pharmacovigilance. Ann Pharmacol Pharm. 2017; 2(3): 1018
9. Amale PN, Deshpande SA, Nakhate YD, Arsod NA (2018) Pharmacovigilance Process in India: An overview. J Pharmacovigil 6: 259.doi:10.4172/2329-6887.1000259
10. Masurkar, Prajakta. (2017). A need of better pharmacovigilance system in India. Asian Journal of Pharmaceutical and Clinical Research. 10. 22-24. 10.22159/ajpcr.2017.v10i1.14797.
11. Haile, D. B., Ayen, W. Y., and Tiwari, P. (2013). Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India. Ethiopian journal of health sciences, 23(1), 39–48.
12. Suke, S. G., Kosta, P., and Negi, H. (2015). Role of Pharmacovigilance in India: An overview. Online journal of public health informatics, 7(2), e223. doi:10.5210/ojphi.v7i2.5595
13. Pharmacovigilance Programme of India : Guidance Document for Spontaneous Adverse Drug Reaction Reporting 2014
14. Bavdekar SB, Karande S. National pharmacovigilance program. Indian Pediatr 2006; 43:27-32.2.
15. Kumar, Duvvuru Ashok; Reddenna, Languluri; Basha, Shaik Ayub. (2015). Pharmacovigilance Programme of India. University of Minnesota, College of Pharmacy. Retrieved from the University of Minnesota Digital Conservancy, http://hdl.handle.net/ 11299/172047
16. Kalaiselvan V, Kumar P, Mishra P, Singh GN. System of adverse drug reactions reporting: What, where, how, and whom to report?. Indian J Crit Care Med. 2015;19(9):564-6.
17. Annu Priyanka ADR monitoring: An essential need for better Health care and Safety; Pharma Tutor; 2016; 4(8); 13-16
18. Kalaivani M, Kalaiselvan V, Dabhi K and Singh GN (2015) Direct Consumer Reporting of ADRs to PvPI, a Position Paper of Indian Pharmacopoeia Commission. Adv Pharmacoepidemiol Drug Saf 4: 184. doi:10.4172/2167-1052.1000184
19. Harmeet Singh, Status of Pharmacovigilance Program of India, Tamil Nadu J. Veterinary and Animal Sciences 9(6) 417 - 420, November - December 2013
20. S Patil, A New Era Of Drug Safety And Pharmacovigilance. J MGIMS, March 2012, Volume 17, No (i), 8 – 12
21. National Pharmacovigilance Protocol, Ministry of Health and Family Welfare, Government of India
22. IPC, Guidance Document Materiovigilance Programme of India (MvPI), version 1.1, https://www.ipc.gov.in/images/ Guidance_Document_Materiovigilance_Programme_of_India_version_1.1.pdf
23. Rajanandh MG, Praveen Kumar V, Yuvasakthi S (2016) Roles of Pharmacist in Pharmacovigilance: A Need of the Hour. J Pharmacovigil 4: 221. doi:10.4172/2329-6887.1000221
24. A.C. van Grootheest, L.T.W. de Jong-van den Berg, The role of hospital and community pharmacists in pharmacovigilance, Research in Social and Administrative Pharmacy, Volume 1, Issue 1, 2005, Pages 126-133
25. Toklu, H. Z., and Mensah, E. (2016). Why do we need pharmacists in pharmacovigilance systems?. Online journal of public health informatics, 8(2), e193. doi:10.5210/ojphi.v8i2.6802
26. Misra, Arup and Thaware, Prafulla and Sutradhar, Shanta and Rapelliwar, Anil and Varma, Sushil. (2013). Pharmacovigilance: Barriers and Challenges.. Mintage J Pharm Med Sci. 2. 35-36.
27. Sethi and Ushashree, Pharmacovigilance: Challenges in India, J Pharmacovigil 2016, Volume 4 Issue 1, DOI: 10.4172/2329-6887.1000194.
28. Biswas P. Pharmacovigilance: Safety matters. Indian J Pharmacol 2008;40:1-2.